Literature DB >> 29887680

Spectrum of Disease and Prescription Pattern for Outpatients with Neurological Disorders: An Empirical Pilot Study in Bangladesh.

Md Sahab Uddin1, Abdullah Al Mamun1, Md Asaduzzaman1, Fakhrul Hosn1, Mohammad Abu Sufian1, Shinya Takeda2, Oscar Herrera-Calderon3, Mohamed M Abdel-Daim4, G M Sala Uddin1, Md Ali Asif Noor1, Mst Marium Begum5, Md Tanvir Kabir6, Sonia Zaman1, Md Shahid Sarwar7, Md Mosiqur Rahman1, Md Rajdoula Rafe1, Md Farhad Hossain8, Md Sarwar Hossain1, Mohammed Ashraful Iqbal9, Md Ataur Rahman Sujan10.   

Abstract

BACKGROUND: Neurological disorders represent one of the most prominent causes of morbidity and mortality that adversely affect the lifestyle of patients and a major percentage of these diseases exists in developing countries.
PURPOSE: The objective of this study was to examine the prevalence and prescription pattern for outpatients with neurological disorders in Bangladesh.
METHODS: The study was conducted on 1,684 patients in 6 hospitals (National Institute of Neurosciences and Hospital, Dhaka Medical College and Hospital, Bangabandhu Sheikh Mujib Medical University, Shaheed Suhrawardy Medical College, Sir Salimullah Medical College, and Apollo Hospitals Dhaka) of the Dhaka City from March 2014 to June 2015. Data were collected through a predesigned questionnaire from the patients that contain information about gender, age, marital status, occupation, residential status, affected disease, self-medicated medicines, and prescribed medicines.
RESULTS: Out of 1,684 patients, 28.38% patients were aged 51-60 years and male, 57.19% predominance. The study exposed headache and migraine for 29.75% patients, followed by stroke for 23.93% patients and seizure for 7.07% patients. Genetic reason for the neurological disorders was seen only among 12.35% patients. In this study, 16.98% patients had been affected by neurological disorders for more than 2 years and 19% of patients for less than 6 months. Most extensively prescribed medicines were multivitamins and multiminerals used by 17.89% of patients followed by nonsteroidal anti-inflammatory drugs and other analgesic by 14.84%; afterwards antiulcerants were used by 12.62%, subsequently anticoagulants were used by 11.61% followed by antihyperlipidemic medicines by 10.26% and antiepileptic drugs by 8.08% of patients. The crucial reasons for the selection of prescribed medicines were the confidence that patients had with the physician's prescribed medicines, which was shown for 40.97% patients and knowledge of the medicines was reported for 35.04% patients. The period of prescribed medicine usage was 1-3 months for 39.73% patients and 3-6 months for 29.16% patients. The patient's compliance for prescribed medicines was satisfactory for 34.56% patients, good for 28.15% patients, and side effects were reported for 23.22% patients.
CONCLUSION: In Bangladesh, it is not surprising to note that neurological diseases are more prevalent than other different diseases among different age groups and genders. Headache and migraine, stroke and seizure are most frequently encountered neurological disorders here. Treatment procedure of these disorders is not quite suitable due to the anomalies of health care management systems. Appropriate management of the health care system, especially the placement of hospital and community pharmacy can overcome the existing inconsistencies as well as increase the knowledge, awareness, and perception of the patients about health and neurological disorders.

Entities:  

Keywords:  Community pharmacy; Health care; Hospital pharmacy; Multiminerals; Multivitamins; Neurological disorders; Nonsteroidal anti-inflammatory drugs; Outpatients

Year:  2017        PMID: 29887680      PMCID: PMC5981591          DOI: 10.1159/000481812

Source DB:  PubMed          Journal:  Ann Neurosci        ISSN: 0972-7531


  33 in total

Review 1.  Organization of neurology services in India: unmet needs and the way forward.

Authors:  Mandaville Gourie-Devi
Journal:  Neurol India       Date:  2008 Jan-Mar       Impact factor: 2.117

Review 2.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

3.  Headache disorders: differentiating and managing the common subtypes.

Authors:  Fayyaz Ahmed
Journal:  Br J Pain       Date:  2012-08

4.  The global burden of neurologic diseases.

Authors:  Jerome H Chin; Nirali Vora
Journal:  Neurology       Date:  2014-07-22       Impact factor: 9.910

Review 5.  The global burden of headache: a documentation of headache prevalence and disability worldwide.

Authors:  Lj Stovner; K Hagen; R Jensen; Z Katsarava; Rb Lipton; Ai Scher; Tj Steiner; J-A Zwart
Journal:  Cephalalgia       Date:  2007-03       Impact factor: 6.292

Review 6.  Headache disorders in developing countries: research over the past decade.

Authors:  F J Mateen; T Dua; T Steiner; S Saxena
Journal:  Cephalalgia       Date:  2008-08-22       Impact factor: 6.292

7.  A review of neurological disorders presenting at a paediatric neurology clinic and response to anticonvulsant therapy in Gambian children.

Authors:  K J Burton; S Allen
Journal:  Ann Trop Paediatr       Date:  2003-06

8.  Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas.

Authors:  M Gourie-Devi; G Gururaj; P Satishchandra; D K Subbakrishna
Journal:  Neuroepidemiology       Date:  2004-08-05       Impact factor: 3.282

9.  The economic burden of dementia in China, 1990-2030: implications for health policy.

Authors:  Junfang Xu; Jian Wang; Anders Wimo; Laura Fratiglioni; Chengxuan Qiu
Journal:  Bull World Health Organ       Date:  2016-10-18       Impact factor: 9.408

10.  Population challenges for Bangladesh in the coming decades.

Authors:  Peter Kim Streatfield; Zunaid Ahsan Karar
Journal:  J Health Popul Nutr       Date:  2008-09       Impact factor: 2.000

View more
  10 in total

Review 1.  Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.

Authors:  Md Farhad Hossain; Md Sahab Uddin; G M Sala Uddin; Dewan Md Sumsuzzman; Md Siddiqul Islam; George E Barreto; Bijo Mathew; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2019-06-17       Impact factor: 5.590

2.  Astilbin attenuates cerebral ischemia/reperfusion injury by inhibiting the TLR4/MyD88/NF-κB pathway.

Authors:  Jing Li; Zhaowei Gu; Yue Liu; Yu Wang; Min Zhao
Journal:  Toxicol Res (Camb)       Date:  2019-11-18       Impact factor: 3.524

Review 3.  Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.

Authors:  Md Sahab Uddin; Abdullah Al Mamun; Md Tanvir Kabir; Ghulam Md Ashraf; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.590

Review 4.  Combination Drug Therapy for the Management of Alzheimer's Disease.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Abdullah Al Mamun; Philippe Jeandet; Lotfi Aleya; Rasha A Mansouri; Ghulam Md Ashraf; Bijo Mathew; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

5.  The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population.

Authors:  Zhuoran Li; Na Yang; Xiuxia Lei; Chuying Lin; Nan Li; Xinqing Jiang; Xinhua Wei; Banglao Xu
Journal:  J Clin Lab Anal       Date:  2019-06-14       Impact factor: 2.352

6.  Spectrum of neurological disorders in neurology outpatients clinics in urban and rural Sindh, Pakistan: a cross sectional study.

Authors:  Safia Awan; Alam Ibrahim Siddiqi; Ahmed Asif; Naveeduddin Ahmed; Hazim Brohi; Sajad Jalbani; Mohammad Wasay
Journal:  BMC Neurol       Date:  2019-08-13       Impact factor: 2.474

Review 7.  Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Kamal Niaz; Philippe Jeandet; Christophe Clément; Bijo Mathew; Abdur Rauf; Kannan R R Rengasamy; Eduardo Sobarzo-Sánchez; Ghulam Md Ashraf; Lotfi Aleya
Journal:  Molecules       Date:  2020-03-11       Impact factor: 4.411

Review 8.  Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Md Sohanur Rahman; Tapan Behl; Philippe Jeandet; Ghulam Md Ashraf; Agnieszka Najda; May N Bin-Jumah; Hesham R El-Seedi; Mohamed M Abdel-Daim
Journal:  Int J Mol Sci       Date:  2020-08-14       Impact factor: 5.923

Review 9.  Novel Anti-Alzheimer's Therapeutic Molecules Targeting Amyloid Precursor Protein Processing.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Philippe Jeandet; Bijo Mathew; Ghulam Md Ashraf; Asma Perveen; May N Bin-Jumah; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Oxid Med Cell Longev       Date:  2020-04-29       Impact factor: 6.543

Review 10.  Natural Products for Neurodegeneration: Regulating Neurotrophic Signals.

Authors:  Md Sahab Uddin; Abdullah Al Mamun; Md Motiar Rahman; Philippe Jeandet; Athanasios Alexiou; Tapan Behl; Md Shahid Sarwar; Eduardo Sobarzo-Sánchez; Ghulam Md Ashraf; Amany A Sayed; Ghadeer M Albadrani; Ilaria Peluso; Mohamed M Abdel-Daim
Journal:  Oxid Med Cell Longev       Date:  2021-06-21       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.